Skip to content
NearWave logo

NearWave

NearWave is a YC Winter 2022 (W22) company. Based in Austin, TX, USA; South Bend, IN, USA. Team of 3.

  • Artificial Intelligence
  • Hard Tech
  • Hardware
  • SaaS
  • Medical Devices

About NearWave

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

NearWave builds a handheld near-infrared spectroscopy device that measures tissue biomarkers, including oxygen saturation and hemoglobin concentrations, at depth without ionizing radiation. Oncologists use it to guide breast cancer treatment selection, replacing a trial-and-error approach that can expose patients to months of ineffective therapy and its side effects.

Go-to-market

The device is sold into clinical and research settings, with physicians as the primary users; it is currently cleared for investigational use only.

From the Y Combinator listing

How NearWave describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Helping physicians select the right therapy for breast cancer patients

NearWave makes a handheld imaging device that helps physicians select the right therapy for their breast cancer patients. This prevents patients from suffering through months of side effects caused by unsuccessful treatments.

Facts

Industry
Healthcare / Healthcare -> Medical Devices
Location
Austin, TX, USA; South Bend, IN, USA
Team size
3
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works